1
|
Dai Y, Zhang YG, Zeng J, Hua H, Zhao JN, Li L, Yan LC, Yin ZJ, Wang JB, Tan P, Tan RR, Zeng AQ, Quan YY, Wei P. [Mystery of Yiyin decoction theory: rule discovery and evaluation strategy of atypical pharmacological effects of Chinese medicinal prescription]. Zhongguo Zhong Yao Za Zhi 2022; 47:4261-4268. [PMID: 36046851 DOI: 10.19540/j.cnki.cjcmm.20220713.601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Yi Yin, a famous medical scientist and culinary master in the late Xia Dynasty and early Shang Dynasty, developed the Chinese medicinal liquids and Chinese medicinal prescriptions emerged after that. Chinese medicinal prescriptions have attracted much attention because of their unique advantages in the treatment of chronic multifactorial diseases, representing an important direction of drug discovery in the future. Yiyin decoction theory is the superior form of personalized combined medication with advanced consciousness. It is different from not only the magic bullet theory of single component action but also the connotation of modern multi-target drugs. The core of Yiyin decoction theory can be summarized as compound compatibility, multiple effects, and moderate regulation. Compound compatibility refers to that the formulation of Chinese medicinal prescriptions involves the complex synergy and interactions between sovereign, minister, assistant, and guide medicinal materials. Multiple effects mean that the prescriptions employ a variety of mechanisms to exert comprehensive pharmacological effects of nonlinear feedback. Moderate regulation reflects that the prescriptions can accurately regulate the multiple points of the disease biological network as a whole. To solve the mystery of Yiyin decoction theory, we should not only simply study the known active substances(components) and their independent target effects in the mixture, but also mine the "dark matter" and "dark effect" of Chinese medicinal prescriptions. That is, we should learn the neglected atypical pharmacological effects of Chinese medicinal prescriptions and the multi-point nesting mechanism that plays a precise regulatory function in the body. Yiyin decoction theory focuses on the overall pharmacological effect to reflect the comprehensive clinical value of Chinese medicinal prescriptions, which is of great significance for the development of a new model for the evaluation and application of new Chinese medicinal prescriptions in line with the theory of traditional Chinese medicine.
Collapse
Affiliation(s)
- Ying Dai
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Yi-Guan Zhang
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Jin Zeng
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Hua Hua
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Jun-Ning Zhao
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Li Li
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Liang-Chun Yan
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Zhu-Jun Yin
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Jian-Bo Wang
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Peng Tan
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Rui-Rong Tan
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - An-Qi Zeng
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Yun-Yun Quan
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| | - Ping Wei
- Sichuan Institute for Translational Chinese Medicine,Sichuan Academy of Chinese Medical Sciences,Key Laboratory of Biological Evaluation of Traditional Chinese Medicine Quality of National Administration of Traditional Chinese Medicine,Translational Chinese Medicine Key Laboratory of Sichuan Province,Sichuan Engineering Research Center for Authentic Medicine Formation Principle and Quality Evaluation,Sichuan Engineering Research Center for Authentic Medicine System Development Chengdu 610041,China
| |
Collapse
|
2
|
Zhao JN, Hua H, Dai Y, Fang QM, Li QM, Jiang SY, Xie CG, Yang SJ, Yan LC, Tan P, Yang AD, Wang S. [Dao-di herbs pharmacology and new ideas of Dao-di herbs standard construction]. Zhongguo Zhong Yao Za Zhi 2020; 45:709-714. [PMID: 32237469 DOI: 10.19540/j.cnki.cjcmm.20191226.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Guided by the basic theory of traditional Chinese medicine and using modern scientific methods, Dao-di herbs pharmacology studies the nature, performance, interaction with the body and its clinical application.It is a bridge between the basic research and clinical application of Dao-di herbs. It can objectively describe the law of efficacy of Dao-di herbs, scientifically explain the mechanism of efficacy of Dao-di herbs, explore and establish the standards and methods of Dao-di herbs based on biological effect and clinical efficacy, and provide scientific basis for the special properties, pharmacology and clinical value of Dao-di herbs.Furthermore, we put forward a new idea of building the standard of Dao-di herbs based on the curative effect rather than the origin.The Dao-di herbs standard should come from the systematic research of traditional Dao-di herbs producing areas and form a new characteristic system, through the extraction of environmental, genetic, character, chemical, pharmacological and other characteristics.This standard originates from the tradition, but it is higher than the tradition. It may not have the origin meaning of strict administrative division, but it can better reflect the pharmacological characteristics and excellent clinical value of Dao-di herbs.
Collapse
Affiliation(s)
- Jun-Ning Zhao
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China College of Pharmacy, Sichuan University Chengdu 610041, China
| | - Hua Hua
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China
| | - Ying Dai
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Qing-Mao Fang
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Qing-Miao Li
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China
| | - Shun-Yuan Jiang
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China
| | - Chun-Guang Xie
- Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075, China
| | - Si-Jin Yang
- Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University Hospital Luzhou 646000, China
| | - Liang-Chun Yan
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Peng Tan
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China Affiliated Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075, China
| | - An-Dong Yang
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China
| | - Shu Wang
- Sichuan Standardization Technical Committee of Traditional Chinese Medicine Chengdu 610041, China College of Pharmacy, Sichuan University Chengdu 610041, China
| |
Collapse
|
3
|
Hua H, Yan ZX, Tian WW, Liu L, Sun HB, Zhou XJ, Yan LC, Zhao JN. [Transcriptome and quality evaluation of Sichuan Dao-di herbs Zanthoxylum bungeanum]. Zhongguo Zhong Yao Za Zhi 2020; 45:732-738. [PMID: 32237472 DOI: 10.19540/j.cnki.cjcmm.20191226.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
"Huajiao" is dried ripe fruit peel of Zanthoxylum bungeanum or Z. schinifolium, is konwn as geoherbs, especially the "Dahongpao" cultivated in Hanyuan, Maoxian and Jiulong of Sichuan province. However, the genetic basis of Dao-di "Huajiao" is virtually unknown. The transcriptome of the fruit and leaf from Sichuan(Hanyuan, Jiulong, Lixian, Maoxian), Gansu(Wudu) province and Shaanxi(Fengxian) province was sequenced. Trinity de novo assembling resulted in a total of 177 616 unigenes. Through the KEGG, NR, SwissProt, Trembl, KOG/COG, GO, Pfam database comparision 106 644 annotated Unigene finally, 4 574 deferentially expressed genes were found in fruit between Sichuan and other provinces, including 3 740 up-regulated genes and 834 down-regulated genes. Among the up-regulated genes, 27 up-regulated genes were raleted to terpenoids, and 8 up-regulated genes were related to isoquinoline alkaloid bio-synthesis. Furthermore, it was also showed remarkable differences in groups which enrichment ratio of the diffe-rent expressed gene compared. The different expressed genes were annotated by the KEGG database into plant-pathogen interaction, plant hormone signal transduction and phenylpropanoid biosynthesis in fruit and leaf, but isoflavonoid bio-synthesis and betaine bio-synthesis were significantly different in fruit and leaf. The study laid a certain reference basis for comparison of quality and different expressed gene of Z. bungeanum from different groups.
Collapse
Affiliation(s)
- Hua Hua
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Zhi-Xiang Yan
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Wei-Wei Tian
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Li Liu
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Hong-Bing Sun
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Xian-Jian Zhou
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Liang-Chun Yan
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| | - Jun-Ning Zhao
- Institute of Translational Pharmacology and Clinical Application, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Laboratory for Rapid Detection of Toxicity of Traditional Chinese Medicine in Sichuan Provincial Administration of Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041, China
| |
Collapse
|
4
|
Chen WW, Yan LC, Cao MY, Li XY, Pang SL, Wang Y, Zhang YS. [Effect of lead exposure on the accumulation of copper and iron in central nervous system of rats]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 37:179-185. [PMID: 31189237 DOI: 10.3760/cma.j.issn.1001-9391.2019.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the dynamic changes of copper and iron contents in brain tissue, body fluids and barriers of rats exposed to lead at different periods in order to provide a theoretical basis for the study of the mechanism of lead nerve injury. Methods: Sixty-four healthy adult SPF male SD rats were randomly divided into control group and lead exposure group, after one week of adaptive feeding, rats in the lead exposure group were treated with 250 mg/L lead acetate, and rats in control group were treated with ordinary drinking water, the experimental period was 12 weeks. After exposure for 3, 6, 9 and 12 weeks, the samples including blood, choroid plexus, cerebrospinal fluid, cortex, hippocampus, striatum, hypothalamus, amygdala, substantia nigra and cerebellum were obtained. Lead, copper and iron content in all kinds of samples were detected by Inductively Coupled Plasma Mass Spectrometry(ICP-MS). The measurement data were presented as Mean±SD, Comparison of metal contents in different tissues of rats at different time analyzed using repeated measurement analysis of variance, Two-variable correlation analysis using Spearman correlation test.The relationship between lead exposure experiod and copper and iron in samples was studied by using trend test. Results: After 12 weeks of lead exposure compared with the control group, lead contents in cortex, hippocampus, striatum, hypothalamus, amygdala, substantia nigra and cerebellum of rats were 2.21, 2.44, 2.95, 3.53, 4.01, 1.85 and 2.86 folds of control group, and the differences were statistically significant(P<0.05). At the same time, lead content in blood, cerebrospinal fluid,choroid plexus, brain microvessels and bones increased. The increase rate in the amygdala and cerebrospinal fluid ranked first among brain tissue or barrier,which were 4.01 and 3.0 folds respectively. Compared with the control group, Compared with the control group, copper content in cortex,hippocampus, striatum, hypothalamus,amygdala, cerebellum,blood,cerebrospinal fluid,choroid plexus and cerebral microvasculature showed an increasing trend among rats following 3,6,9,12 weeks of lead exposure. Copper content change in the striatum was highest among all brain tissue. The increase rate of copper content in the striatum was at the top among brain tissues. After 12 weeks of lead exposure,copper content in brain microvessels was 4.98 folds higher than that of the control group (P<0.05). After lead exposure at different periods,the iron content in the cortex, hippocampus, striatum,cerebrospinal fluid,choroid plexus and brain microvessels of experimental rats all increased(P<0.05). And the iron increase rate in the hypothalamus or cerebrospinal fluid increase ranked first among brain tissues or body fluid the most obviously. Conclusion: With the increase of exposure time, lead exposure can changes in the contents of copper and iron in different brain tissues,body fluids and barriers in rats,among which, the contents of copper and iron in the amygdala,cerebrospinal fluid and brain microvessels increase significantly. This may be related to nerve damage from lead exposure.
Collapse
Affiliation(s)
- W W Chen
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China
| | - L C Yan
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China
| | - M Y Cao
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China
| | - X Y Li
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China
| | - S L Pang
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China
| | - Y Wang
- School of Public Health, North China University of Science and Technology, Tangshan 063000, China
| | - Y S Zhang
- Laboratory animal center, North China University of Science and Technology 063000 Tangshan, China
| |
Collapse
|
5
|
Zhang YG, Tan RR, Ren SC, Ma X, Yan ZX, Hua H, Yan LC, Dai Y, Zhao JN. [New method for evaluating pharmacodynamics of traditional Chinese medicine compounds based on its moderate regulation and principle of balanced adjustment of immunity under pan-immunomic]. Zhongguo Zhong Yao Za Zhi 2019; 43:3229-3234. [PMID: 30200723 DOI: 10.19540/j.cnki.cjcmm.20180629.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/20/2018] [Indexed: 11/18/2022]
Abstract
For the basic research on the traditional Chinese medicine(TCM), objective syndrome of traditional Chinese medicine and evaluation criteria of traditional Chinese medicine compounds are hardly to break though. While, the modern immunology points out that the body is a counterbalance state and immune imbalance is the root of sickness. The thinking mode of treating diseases in traditional Chinese medicine is also "balance", considering disease is the result of bias which present the imbalance of "Yin counters Yang", "exterior counters interior", "cold counters heat" and "weak counters strong". The Chinese herbal compound formula preparation was applied on disease therapy based on theory of Chinese medicine, which was confirmed by long period clinical application. It is composed of multi-compounds and has the characteristic of multi-targeting. Integrative medicine has spawned pan-immunomics, and the evaluation of immune function (immune balance) has become an important basis for diagnosis and treatment models of integrative medicine. In addition, balance is the core idea of whole-systemic conception of traditional Chinese medicine. Therefore, we speculate that immune balance under pan-immunomic can bridge the traditional Chinese medicine and modern integrative medicine and is the important basis for objective syndrome of traditional Chinese medicine and evaluation criteria of traditional Chinese medicine compounds. According to the bridging theory, we attempt to utilize informatics and statistical methods to construct an evaluation system for pharmacodynamics of traditional Chinese medicine based on its moderate regulation and the balanced adjustment of immunity under pan-immunomic, which further reveal the scientific essence of the whole-systemic view of traditional Chinese medicine. This research brings out a new valuable strategy and provides a theoretical basis for accelerating the transformation of traditional Chinese medicine, especially the exploitation of Chinese herbal compound formula, and constructing the new drug innovation and review system for traditional Chinese medicine. Besides as a reference for traditional Chinese medicine objective syndrome and pharmacodynamics of traditional Chinese medicine compounds, the evaluation system can screen the immunity of sub-health population also. With the continuous accumulation of clinical sample and data, the evaluation system will be more accurate and intelligent.
Collapse
Affiliation(s)
- Yi-Guan Zhang
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Rui-Rong Tan
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Si-Chong Ren
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Xin Ma
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Zhi-Xiang Yan
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Hua Hua
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Liang-Chun Yan
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Ying Dai
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| | - Jun-Ning Zhao
- Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Institute of Translational Pharmacology of Sichuan Academy of Chinese Medicine Sciences, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center of Chinese Medicine, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China
| |
Collapse
|
6
|
Zhao JN, Hua H, Yang AD, Zhang YG, Dai Y, Li QM, Yan LC, Li XL, Li L, Zeng J, Ren SC, Wang JB. [Generalized science of Chinese material medica-from preventive treatment of disease to Chinese medicine health industry]. Zhongguo Zhong Yao Za Zhi 2018; 43:4177-4181. [PMID: 30583614 DOI: 10.19540/j.cnki.cjcmm.2018.0109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Indexed: 11/18/2022]
Abstract
Based on the systematic summary of the results of the fourth general survey of traditional Chinese medicine resources, the cultivation of large varieties of Chinese material medica and the latest research on health industrial development, the novel concepts and scientific connotations of generalized science of Chinese material medica are put forward, and the basic ideas and methods of a new Chinese medicine academic system, the cultivation system of large varieties of Chinese medicinal materials and the application system of the large health industry are constructed. This kind of generalized science of Chinese material medica, rooted in the traditional Chinese culture and the theory of "preventive treatment of disease", can avoid the narrow prospect induced by the increasing specialization and refinement of knowledge of science of Chinese material medica. It will play an important role in the modernization, industrialization, internationalization of traditional Chinese medicine.
Collapse
Affiliation(s)
- Jun-Ning Zhao
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Hua Hua
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - An-Dong Yang
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Yi-Guan Zhang
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Ying Dai
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Qing-Miao Li
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Liang-Chun Yan
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Xiao-Lu Li
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Li Li
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Jin Zeng
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Si-Chong Ren
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| | - Jian-Bo Wang
- Institute of Translational Pharmacology and Clinical Application of Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, Sichuan Engineering Technology Research Center of Genuine Regional Drug, Biological Assay Key Laboratory of State Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Quality, Sichuan Provincial Key Laboratory of Quality Evaluation and New Drug Creation of Traditional Chinese Medicine, Chengdu 610041, China
| |
Collapse
|
7
|
Gao HL, Li XR, Yan LC, Zhao JN. [Optimization of reaction conditions and methodological investigation on microtox-based fast testing system for traditional Chinese medicine injection]. Zhongguo Zhong Yao Za Zhi 2016; 41:1622-1626. [PMID: 28891609 DOI: 10.4268/cjcmm20160909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Indexed: 06/07/2023]
Abstract
Vibrio fischeri CS234 was used to establish and optimize microtox assay system, laying a foundation for the application of this method in comprehensive acute toxicity test of traditional Chinese medicine (TCM) injections. Firstly, the Plackett-Burman method was carried out to optimize the factors which would affect Vibrio fischeri CS234 luminescence. Secondly, ZnSO4•7H2O was chosen as reference substance to establish its reaction system with quality control samples. The optimal luminescence conditions were achieved as follows: ①At a temperature of (15±1) ℃, Vibrio fischeri CS234 lyophilized powders were balanced for 15 min, then, 1 mL resuscitation fluid was added and blended for 10 min. 100 μL bacteria suspension was taken to measure the initial luminescence intensity, and then 1 mL resuscitation fluid or test sample was immediately added; after reaction for 10 min, corresponding luminescence intensity was measured again. Resuscitation diluent, osmotic pressure regulator and ZnSO4•7H2O stock solution showed no interference to the determination of Vibrio fischeri CS234 luminescence intensity, so this method was of good specificity. The within-and between-batch precisions of quality controls and the lower limit of quantification (LLOQ) samples were <5% and <10% respectively, while the accuracy ranged between 85.8% and 103.2%. The standard curve equation of ZnSO4•7H2O ranged from 3.86 mg•L⁻¹ to 77.22 mg•L⁻¹ (final concentrations) was y=21.78lnx-15.14, R2=0.998; meanwhile, IC₅₀ of ZnSO4•7H2O to Vibrio fischeri CS234 was 19.90 mg•L⁻¹. ZnSO4•7H2O stock solution and its quality controls were continuously investigated for 120 h and 8 h respectively, and their RSD was lower than 2%, indicating stability at room temperature and 4 ℃ storage conditions. Between pH 4.5-8.0, luminescence intensity of Vibrio fischeri CS234 was controlled within ±10%, and such pH value range could meet the testing needs of the vast majority of traditional Chinese medicine injections. The Vibrio fischeri strain CS234 assay system was specific, stable, sensitive, accurate and adaptable after optimization, so it was suitable for the comprehensive acute toxicity assessment of TCM injections.
Collapse
Affiliation(s)
- Hong-Li Gao
- Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
- Sichuan Academy of Chinese Medicine Sciences, Biological Evaluation of Traditional Chinese Medicine Quality of the State Administration of Traditional Chinese Medicine, Chengdu 610041, China
| | - Xiao-Rong Li
- Sichuan Academy of Chinese Medicine Sciences, Biological Evaluation of Traditional Chinese Medicine Quality of the State Administration of Traditional Chinese Medicine, Chengdu 610041, China
| | - Liang-Chun Yan
- Sichuan Academy of Chinese Medicine Sciences, Biological Evaluation of Traditional Chinese Medicine Quality of the State Administration of Traditional Chinese Medicine, Chengdu 610041, China
| | - Jun-Ning Zhao
- Sichuan Academy of Chinese Medicine Sciences, Biological Evaluation of Traditional Chinese Medicine Quality of the State Administration of Traditional Chinese Medicine, Chengdu 610041, China
| |
Collapse
|
8
|
Griffin JW, George R, Lobato C, Tyor WR, Yan LC, Glass JD. Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination. J Neuroimmunol 1992; 40:153-65. [PMID: 1430148 DOI: 10.1016/0165-5728(92)90129-9] [Citation(s) in RCA: 112] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Macrophages are important effector cells in immune-mediated demyelination. Current concepts regarding their entry and activation focus on the effects of T-cell-derived cytokines. This presentation describes the responses of macrophages and microglia to a non-inflammatory, non-immune injury, Wallerian degeneration. During Wallerian degeneration in the peripheral nervous system (PNS), macrophages are promptly and abundantly recruited from the circulation, and myelin clearance is prompt. In the central nervous system (CNS), the appearance of macrophages is markedly slower, and entry from the circulation is modest or absent. Myelin clearance is similarly delayed. The nature of the factors promoting macrophage entry and activation in Wallerian degeneration, and the bases for the differences between PNS and CNS, are relevant to current issues in immune-mediated demyelination.
Collapse
Affiliation(s)
- J W Griffin
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205
| | | | | | | | | | | |
Collapse
|
9
|
Yan LC, Su WJ. [Gall bladder stone (author's transl)]. Hu Li Za Zhi 1974; 21:66-70. [PMID: 4497885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|